We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

No Llamas Required

News   Feb 15, 2018 | Original Story by Stephanie Dutchen for Harvard Medical School.

 
No Llamas Required
 
 
 

RELATED ARTICLES

Study Finds Commercially Available Antibodies Are Not Binding Their Target

News

In a new study, researchers have tested the binding specificity of commercial antibodies to the C9ORF72 protein, and explored a novel validation approach.

READ MORE

"Exhausted" T Cells Lose the Battle Against Disease

News

A new study has identified the molecular mechanisms behind which T cells will lose the battle against cancer earlier, which could inform treatment.

READ MORE

Personalized Immunotherapy Refined by Mass Spec-Machine Learning Pairing

News

A combination of mass spectrometry and a novel computational tool is more accurately identifying the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE